These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

120 related items for PubMed ID: 7372059

  • 1. Hepatotoxic effect of bile acids in inflammatory bowel disease.
    Dew MJ, van Berge Henegouwen GP, Huybregts AW, Allan RN.
    Gastroenterology; 1980 Jun; 78(6):1393-401. PubMed ID: 7372059
    [Abstract] [Full Text] [Related]

  • 2. Hepatic alterations during total parenteral nutrition in patients with inflammatory bowel disease: a possible consequence of lithocholate toxicity.
    Fouin-Fortunet H, Le Quernec L, Erlinger S, Lerebours E, Colin R.
    Gastroenterology; 1982 May; 82(5 Pt 1):932-7. PubMed ID: 6800873
    [Abstract] [Full Text] [Related]

  • 3. The lack of relationship between hepatotoxicity and lithocholic-acid sulfation in biliary bile acids during chenodiol therapy in the National Cooperative Gallstone Study.
    Fisher RL, Hofmann AF, Converse JL, Rossi SS, Lan SP.
    Hepatology; 1991 Sep; 14(3):454-63. PubMed ID: 1874490
    [Abstract] [Full Text] [Related]

  • 4. Biochemical epidemiology of gallbladder cancer.
    Strom BL, Soloway RD, Rios-Dalenz J, Rodriguez-Martinez HA, West SL, Kinman JL, Crowther RS, Taylor D, Polansky M, Berlin JA.
    Hepatology; 1996 Jun; 23(6):1402-11. PubMed ID: 8675157
    [Abstract] [Full Text] [Related]

  • 5. Metabolism of lethocholate in healthy man. I. Biotransformation and biliary excretion of intravenously administered lithocholate, lithocholylglycine, and their sulfates.
    Cowen AE, Korman MG, Hofmann AF, Cass OW.
    Gastroenterology; 1975 Jul; 69(1):59-66. PubMed ID: 1150035
    [Abstract] [Full Text] [Related]

  • 6. Serum bile acids and ursodeoxycholic acid treatment in cystic fibrosis-related liver disease.
    O'Brien SM, Campbell GR, Burke AF, Maguire OC, Rowlands BJ, FitzGerald MX, Hegarty JE.
    Eur J Gastroenterol Hepatol; 1996 May; 8(5):477-83. PubMed ID: 8804877
    [Abstract] [Full Text] [Related]

  • 7. The spectrum of hepatic dysfunction in inflammatory bowel disease.
    Dew MJ, Thompson H, Allan RN.
    Q J Med; 1979 Jan; 48(189):113-35. PubMed ID: 482586
    [Abstract] [Full Text] [Related]

  • 8. Metabolism and effect of 7-oxo-lithocholic acid 3-sulfate on bile flow and biliary lipid secretion in rats.
    Yamashita H, Setchell KD.
    Hepatology; 1994 Sep; 20(3):663-71. PubMed ID: 8076924
    [Abstract] [Full Text] [Related]

  • 9. Metabolism of lithocholate in healthy man. III. Plasma disappearance of radioactivity after intravenous injection of labeled lithocholate and its derivatives.
    Cowen AE, Korman MG, Hofmann AF, Thomas PJ.
    Gastroenterology; 1975 Jul; 69(1):77-82. PubMed ID: 1150037
    [Abstract] [Full Text] [Related]

  • 10. Impaired lithocholate sulfation in the rhesus monkey: a possible mechanism for chenodeoxycholate toxicity.
    Gadacz TR, Allan RN, Mack E, Hofmann AF.
    Gastroenterology; 1976 Jun; 70(6):1125-9. PubMed ID: 817960
    [Abstract] [Full Text] [Related]

  • 11. Lithocholate detoxification and biliary secretion in the rat.
    Pattinson NR, Chapman BA.
    Biochem Int; 1984 Aug; 9(2):137-42. PubMed ID: 6487341
    [Abstract] [Full Text] [Related]

  • 12. Bile acids in liver disease associated with inflammatory bowel disease.
    Siegel JH, Barnes S, Morris JS.
    Digestion; 1977 Aug; 15(6):469-81. PubMed ID: 913913
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Comparison of the effects between ursodeoxycholic and chenodeoxycholic acids on liver function and structure and bile acid composition in the Rhesus Monkey.
    Sarva RP, Fromm H, Farivar S, Sembrat RF, Mendelow H, Shinozuka H, Wolfson SK.
    Gastroenterology; 1980 Oct; 79(4):629-36. PubMed ID: 7409382
    [Abstract] [Full Text] [Related]

  • 16. Taurine and glycine conjugation and sulfation of lithocholate in primary hepatocyte cultures.
    Galle PR, Theilmann L, Raedsch R, Rudolph G, Kommerell B, Stiehl A.
    Biochim Biophys Acta; 1989 Jun 28; 1003(3):250-3. PubMed ID: 2742861
    [Abstract] [Full Text] [Related]

  • 17. Differing effects of nor-ursodeoxycholic or ursodeoxycholic acid on hepatic histology and bile acid metabolism in the rabbit.
    Cohen BI, Hofmann AF, Mosbach EH, Stenger RJ, Rothschild MA, Hagey LR, Yoon YB.
    Gastroenterology; 1986 Jul 28; 91(1):189-97. PubMed ID: 3710068
    [Abstract] [Full Text] [Related]

  • 18. Differences in the metabolism and disposition of ursodeoxycholic acid and of its taurine-conjugated species in patients with primary biliary cirrhosis.
    Invernizzi P, Setchell KD, Crosignani A, Battezzati PM, Larghi A, O'Connell NC, Podda M.
    Hepatology; 1999 Feb 28; 29(2):320-7. PubMed ID: 9918905
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Relationship between biliary and serum bile acids and response to ursodeoxycholic acid in patients with primary biliary cirrhosis.
    Lindor KD, Lacerda MA, Jorgensen RA, DeSotel CK, Batta AK, Salen G, Dickson ER, Rossi SS, Hofmann AF.
    Am J Gastroenterol; 1998 Sep 28; 93(9):1498-504. PubMed ID: 9732932
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.